Research Grade Felvizumab
Felvizumab[HuRSV19VHFNS/VK, RSHZ19, RSVmonoclonalantibody, SB209763]isahumanisedmonoclonalantibody (IgG1) preparedbythehumanizationofanFprotein-specificmurineMAb.Ininvitrostudies, palivizumab, anotherhumanizedMabspecificfortheFproteinofRSV, was4to5-foldmorepotentthanfelvizumabinneutralisingRSV (Scott,1999) .RSHZ19 (Felvizumab) RSVThisantibodywas
Product Specifications
Product Name Alternative
SB209763, HuRSV19VHFNS/VK, RSHZ19monoclonalantibody, SB209763, CAS:167747-20-8
Expression System
Mammalian Cells
Host
Humanized
Target
F, FusionglycoproteinF0, FusionglycoproteinF2, p27, Interveningsegment, Pep27, Peptide27, FusionglycoproteinF1
Clonality
Monoclonal
Applications
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Purification
Protein A/G purified from cell culture supernatant.
Concentration
1mg/ml
Endotoxin
Please contact with the lab for this information.
Purity
>95% as determined by SDS-PAGE.
Form
Liquid
Buffer
0.01M PBS, pH7.4.
Storage Conditions
Notes
For research use only. Not suitable for clinical or therapeutic use.
Buffer pH
0.01M PBS, pH7.4.
Species
HRSV-A
Isotype
IgG1, kappa
Available Sizes
Explore Other Products
Browse additional items from our catalog
Lentiviral human DCST1 shRNA (UAS) - Lentiviral human DCST1 shRNA (UAS, GFP) (25)
(2E)-3-(4-Phenoxyphenyl)-2-propenoic Acid Ethyl Ester
